XML 43 R31.htm IDEA: XBRL DOCUMENT v3.26.1
Stock Options (Tables)
3 Months Ended
Mar. 31, 2026
Stock Options and Restricted Stock  
Summary of weighted average assumptions used in the model for valuing stock option grants

The weighted average assumptions used in the model for valuing stock options grants for the three months ended March 31, 2026 are as follows:

March 31, 

  ​ ​ ​

2026

  ​ ​ ​

Dividend Yield

 

%  

Expected Life

 

7

Years

Expected Volatility

 

30.92

%  

Risk-Free Interest Rate

 

3.95

%  

Summary of the status of the Company's outstanding stock options

The following table presents a summary of the status of the Company’s outstanding stock options for the three months ended March 31, 2026:

March 31, 2026

  ​ ​ ​

  ​ ​ ​

  ​ ​ ​

Weighted

Average

Shares

Exercise Price

Outstanding at Beginning of Year

 

1,935,175

$

11.59

Granted

 

25,000

 

17.53

Exercised

 

(30,400)

 

10.70

Forfeitures

 

 

Outstanding at Period End

 

1,929,775

$

11.68

Options Exercisable at Period End

 

1,460,524

$

11.17

Summary of information pertaining to options outstanding based on range of exercise price

The following table presents information pertaining to options outstanding at March 31, 2026:

Options Outstanding

Options Exercisable

Weighted Average

Number of

Weighted Average

Remaining Contractual

Number of

Weighted Average

Range of Exercise Prices

  ​ ​ ​

Options

  ​ ​ ​

Exercise Price

Life in Years

Options

  ​ ​ ​

Exercise Price

$

7.00 - 7.99

 

642,392

 

$

7.47

 

1.5

 

642,392

 

$

7.47

8.00 - 8.99

 

2,961

 

8.76

 

4.0

 

2,961

 

8.76

10.00 - 10.99

190,000

10.65

7.3

82,249

10.65

11.00 - 11.99

203,625

11.17

6.0

130,875

11.21

12.00 - 12.99

245,297

12.91

3.3

245,297

12.91

13.00 - 13.99

285,000

13.75

8.8

71,250

13.75

17.00 - 17.99

310,500

17.50

6.2

285,500

17.50

18.00 - 18.99

50,000

18.03

9.7

Totals

 

1,929,775

$

11.68

4.8

 

1,460,524

$

11.17

Summary of analysis of nonvested options to purchase shares of the Company's stock issued and outstanding

The following table presents an analysis of nonvested options to purchase shares of the Company’s stock issued and outstanding for the three months ended March 31, 2026:

  ​ ​ ​

  ​ ​ ​

  ​ ​ ​

Weighted

Number of

Average Grant

Shares

Date Fair Value

Nonvested Options at December 31, 2025

 

584,251

$

5.69

Granted

 

25,000

7.24

Vested

 

(140,000)

5.55

Forfeited

Nonvested Options at March 31, 2026

 

469,251

$

5.82

Summary of the status of the Company's outstanding restricted stock units

The following table presents an analysis of nonvested restricted stock units outstanding for the three months ended March 31, 2026:

  ​ ​ ​

  ​ ​ ​

  ​ ​ ​

Weighted

Number of

Average Grant

Units

Date Fair Value

Nonvested at December 31, 2025

 

447,661

$

15.24

Granted

 

64,419

19.54

Vested

 

(50,373)

13.93

Forfeited

(1,421)

18.05

Nonvested at March 31, 2026

 

460,286

$

15.97